Literature DB >> 12196582

Mammalian achaete scute homolog 2 is expressed in the adult sciatic nerve and regulates the expression of Krox24, Mob-1, CXCR4, and p57kip2 in Schwann cells.

Patrick Küry1, Regine Greiner-Petter, Christiane Cornely, Tim Jürgens, Hans Werner Müller.   

Abstract

The molecular control mechanisms and regulatory molecules involved in nerve repair are not yet well known. Schwann cells have been attributed an important role in peripheral nerve regeneration; therefore, attention has been drawn to regulatory factors expressed by these glial cells. Here, we demonstrate that Mash2, a basic helix-loop-helix (bHLH) transcription factor previously shown to be crucial for placenta development, is expressed by Schwann cells of adult peripheral nerves. We observed that this gene is downregulated after nerve lesion and, using cDNA array hybridization technology, we could demonstrate that Mash2 is a regulator of Krox24, Mob-1, and CXCR4 expression in cultured Schwann cells. In addition, we provide strong evidence that Mash2 is a negative regulator of Schwann cell proliferation. Mash2 represents a first candidate for the missing class B bHLH proteins in peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196582      PMCID: PMC6758000     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  19 in total

Review 1.  Chemokines: integrators of pain and inflammation.

Authors:  Fletcher A White; Sonia K Bhangoo; Richard J Miller
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

2.  The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination.

Authors:  André Heinen; David Kremer; Peter Göttle; Fabian Kruse; Birgit Hasse; Helmar Lehmann; Hans Peter Hartung; Patrick Küry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

Review 3.  Negative regulators of schwann cell differentiation-novel targets for peripheral nerve therapies?

Authors:  André Heinen; Helmar C Lehmann; Patrick Küry
Journal:  J Clin Immunol       Date:  2012-09-06       Impact factor: 8.317

Review 4.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

5.  Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.

Authors:  Mona Freidin; Samantha Asche-Godin; Charles K Abrams
Journal:  Exp Neurol       Date:  2014-10-23       Impact factor: 5.330

6.  Ascl2 inhibits myogenesis by antagonizing the transcriptional activity of myogenic regulatory factors.

Authors:  Chao Wang; Min Wang; Justine Arrington; Tizhong Shan; Feng Yue; Yaohui Nie; Weiguo Andy Tao; Shihuan Kuang
Journal:  Development       Date:  2016-12-19       Impact factor: 6.868

7.  CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.

Authors:  Sonia K Bhangoo; Dongjun Ren; Richard J Miller; David M Chan; Matthew S Ripsch; Clarissa Weiss; Christian McGinnis; Fletcher A White
Journal:  Brain Behav Immun       Date:  2007-02-09       Impact factor: 7.217

8.  Ascl3 expression marks a progenitor population of both acinar and ductal cells in mouse salivary glands.

Authors:  Tara Bullard; Laurie Koek; Elisa Roztocil; Paul D Kingsley; Lily Mirels; Catherine E Ovitt
Journal:  Dev Biol       Date:  2008-04-23       Impact factor: 3.582

9.  A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells.

Authors:  Oriella Andresini; Agnese Ciotti; Marianna N Rossi; Cecilia Battistelli; Mariarosaria Carbone; Rossella Maione
Journal:  Epigenetics       Date:  2016-09-09       Impact factor: 4.528

10.  Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy.

Authors:  Sonia K Bhangoo; Matthew S Ripsch; David J Buchanan; Richard J Miller; Fletcher A White
Journal:  Mol Pain       Date:  2009-08-12       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.